The inhibitory effects of Naringenin on proliferation and migration of C۶ glioblastoma cell line

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 142

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CSUMSMED07_173

تاریخ نمایه سازی: 20 دی 1401

چکیده مقاله:

Background and aim: Gliomas are the most prevalent type of malignant primary brain tumors with poor prognostic features. The aberrant Hedgehog-Gli pathway as highly conserved signaling has been found to be involved in the development of numerous malignancies including gliomas. Naringenin appears to have anti-cancer properties. The present research was set to study the anti-cancer effects of naringenin on cells to determine the effect of this compound on the Hh signaling pathway.Materials and method: The apoptotic and the anti-proliferative effects of naringenin against cells were measured by Annexin-V/PI dual staining assay and MTT assay, respectively. To analyze the anti-cancer effect of naringenin on the Hh signaling pathway, the protein expression levels of Gli-۱, Smo, and Sufu in cells were measured using western blotting. In addition, the effect of naringenin on the migration of cells was assessed by migration scratch assay.Results: Obtained data showed that naringenin induced higher cytotoxicity against cells than normal ۳T۳ fibroblasts with an IC۵۰ value of ۱۲۵ μg/ml. Naringenin (۱۲۵ μg/ml) also induced stronger apoptotic effects on cells than ۳T۳ cells after ۲۴ h of incubation. In addition, naringenin at a concentration of ۱۲۵ μg/ml significantly reduced the expression of Gli-۱ and Smo as well as increased the expression of Sufu at the protein level in the cell line. Furthermore, naringenin at concentrations of ۶۲ and ۱۲۵ μg/ml attenuated the migration of the cell line.Conclusion: These data indicate that naringenin may have a potential effect on the management of the proliferation and metastasis of malignant gliomas by attenuating the Hh signaling pathway.

نویسندگان

Kobra Bahrampour Juybari

Department of Pharmacology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

Marzieh Lotfian Sargazi

Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

Mojdeh Esmaeili Tazi

Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran

Arian Amirkhosravi

Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran

Mohammad Hadi Nematollahi

Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

Solmaz Mirzamohammadi

School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran